349 related articles for article (PubMed ID: 27847820)
21. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.A11.
Hansen SK; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Stummann TC; Fog K; Hyttel P
Stem Cell Res; 2016 May; 16(3):553-6. PubMed ID: 27346190
[TBL] [Abstract][Full Text] [Related]
22. Autophagy in Spinocerebellar Ataxia Type 3: From Pathogenesis to Therapeutics.
Paulino R; Nóbrega C
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108570
[TBL] [Abstract][Full Text] [Related]
23. Generation of two induced pluripotent stem cell lines, GZHMCi009-A and GZHMCi010-A, derived from peripheral blood mononuclear cells of two SCA3 patients with 14/74 CAG repeats of the ATXN3 mutation.
Yinghong Y; Qian L; Bing S; Yingjun X; Wenzhi H; Bangzhu C; Xiaofang S
Stem Cell Res; 2022 May; 61():102782. PubMed ID: 35421843
[TBL] [Abstract][Full Text] [Related]
24. Anti-Excitotoxic Effects of N-Butylidenephthalide Revealed by Chemically Insulted Purkinje Progenitor Cells Derived from SCA3 iPSCs.
Yang HH; Chiang IT; Liu JW; Hsieh J; Lee JH; Lu HE; Tso HS; Deng YC; Kao JC; Wu JR; Harn HJ; Chiou TW
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163312
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological enhancement of retinoid-related orphan receptor α function mitigates spinocerebellar ataxia type 3 pathology.
Watanave M; Hoshino C; Konno A; Fukuzaki Y; Matsuzaki Y; Ishitani T; Hirai H
Neurobiol Dis; 2019 Jan; 121():263-273. PubMed ID: 30343032
[TBL] [Abstract][Full Text] [Related]
26. A fine balance between Prpf19 and Exoc7 in achieving degradation of aggregated protein and suppression of cell death in spinocerebellar ataxia type 3.
Chen ZS; Huang X; Talbot K; Chan HYE
Cell Death Dis; 2021 Feb; 12(2):136. PubMed ID: 33542212
[TBL] [Abstract][Full Text] [Related]
27. Molecular Mechanisms and Cellular Pathways Implicated in Machado-Joseph Disease Pathogenesis.
Nóbrega C; Simões AT; Duarte-Neves J; Duarte S; Vasconcelos-Ferreira A; Cunha-Santos J; Pereira D; Santana M; Cavadas C; de Almeida LP
Adv Exp Med Biol; 2018; 1049():349-367. PubMed ID: 29427113
[TBL] [Abstract][Full Text] [Related]
28. [Polyglutamine-expanded ataxin-3 is degraded by autophagy].
Xiao H; Tang J; Hu Z; Tan J; Tang B; Jiang Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):23-8. PubMed ID: 20140862
[TBL] [Abstract][Full Text] [Related]
29. Transcription factor EB-mediated mesenchymal stem cell therapy induces autophagy and alleviates spinocerebellar ataxia type 3 defects in neuronal cells model.
Han X; de Dieu Habimana J; Li AL; Huang R; Mukama O; Deng W; Wang L; Zhang Y; Wang W; Deng S; Peng K; Ni B; Zhang S; Huang J; Yan XX; Li Z
Cell Death Dis; 2022 Jul; 13(7):622. PubMed ID: 35851059
[TBL] [Abstract][Full Text] [Related]
30. CRISPR/Cas9 mediated gene correction ameliorates abnormal phenotypes in spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cells.
He L; Wang S; Peng L; Zhao H; Li S; Han X; Habimana JD; Chen Z; Wang C; Peng Y; Peng H; Xie Y; Lei L; Deng Q; Wan L; Wan N; Yuan H; Gong Y; Zou G; Li Z; Tang B; Jiang H
Transl Psychiatry; 2021 Sep; 11(1):479. PubMed ID: 34535635
[TBL] [Abstract][Full Text] [Related]
31. Removal of the Polyglutamine Repeat of Ataxin-3 by Redirecting pre-mRNA Processing.
McIntosh CS; Aung-Htut MT; Fletcher S; Wilton SD
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31683630
[TBL] [Abstract][Full Text] [Related]
32. Fibroblasts of Machado Joseph Disease patients reveal autophagy impairment.
Onofre I; Mendonça N; Lopes S; Nobre R; de Melo JB; Carreira IM; Januário C; Gonçalves AF; de Almeida LP
Sci Rep; 2016 Jun; 6():28220. PubMed ID: 27328712
[TBL] [Abstract][Full Text] [Related]
33. ASOs are an effective treatment for disease-associated oligodendrocyte signatures in premanifest and symptomatic SCA3 mice.
Schuster KH; Zalon AJ; DiFranco DM; Putka AF; Stec NR; Jarrah SI; Naeem A; Haque Z; Zhang H; Guan Y; McLoughlin HS
Mol Ther; 2024 May; 32(5):1359-1372. PubMed ID: 38429929
[TBL] [Abstract][Full Text] [Related]
34. Alteration of methylation status in the ATXN3 gene promoter region is linked to the SCA3/MJD.
Wang C; Peng H; Li J; Ding D; Chen Z; Long Z; Peng Y; Zhou X; Ye W; Li K; Xu Q; Ai S; Song C; Weng L; Qiu R; Xia K; Tang B; Jiang H
Neurobiol Aging; 2017 May; 53():192.e5-192.e10. PubMed ID: 28094059
[TBL] [Abstract][Full Text] [Related]
35. Impaired Oligodendrocyte Maturation Is an Early Feature in SCA3 Disease Pathogenesis.
Schuster KH; Zalon AJ; Zhang H; DiFranco DM; Stec NR; Haque Z; Blumenstein KG; Pierce AM; Guan Y; Paulson HL; McLoughlin HS
J Neurosci; 2022 Feb; 42(8):1604-1617. PubMed ID: 35042771
[TBL] [Abstract][Full Text] [Related]
36. Population genetics and new insight into range of CAG repeats of spinocerebellar ataxia type 3 in the Han Chinese population.
Gan SR; Ni W; Dong Y; Wang N; Wu ZY
PLoS One; 2015; 10(8):e0134405. PubMed ID: 26266536
[TBL] [Abstract][Full Text] [Related]
37. Far-infrared Radiation Improves Motor Dysfunction and Neuropathology in Spinocerebellar Ataxia Type 3 Mice.
Liu SW; Chang JC; Chuang SF; Liu KH; Cheng WL; Chang HJ; Chang HS; Lin TT; Hsieh CL; Lin WY; Hsieh M; Kuo SJ; Liu CS
Cerebellum; 2019 Feb; 18(1):22-32. PubMed ID: 29725949
[TBL] [Abstract][Full Text] [Related]
38. Toward therapeutic targets for SCA3: Insight into the role of Machado-Joseph disease protein ataxin-3 in misfolded proteins clearance.
Li X; Liu H; Fischhaber PL; Tang TS
Prog Neurobiol; 2015 Sep; 132():34-58. PubMed ID: 26123252
[TBL] [Abstract][Full Text] [Related]
39. From Pathogenesis to Novel Therapeutics for Spinocerebellar Ataxia Type 3: Evading Potholes on the Way to Translation.
Da Silva JD; Teixeira-Castro A; Maciel P
Neurotherapeutics; 2019 Oct; 16(4):1009-1031. PubMed ID: 31691128
[TBL] [Abstract][Full Text] [Related]
40. Silencing mutant ATXN3 expression resolves molecular phenotypes in SCA3 transgenic mice.
Rodríguez-Lebrón E; Costa Mdo C; Luna-Cancalon K; Peron TM; Fischer S; Boudreau RL; Davidson BL; Paulson HL
Mol Ther; 2013 Oct; 21(10):1909-18. PubMed ID: 23820820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]